Sat.Jan 11, 2020 - Fri.Jan 17, 2020

article thumbnail

Drug development from bench to bedside

Deltaclinical

Yesterday we attended the symposium ‘Drug Development from Bench to Bedside’, organised by the University Hospital of Ghent. It was an interesting day on a great location with inspiring lectures. We’re looking forward to part 2 today. Find out more about the symposium.

article thumbnail

Changes to Pediatric Study Plan Requirements for Oncology Drug Products: Are You Prepared?

Camargo

If you are planning to submit a New Drug Application (NDA) for an oncology drug. The post Changes to Pediatric Study Plan Requirements for Oncology Drug Products: Are You Prepared? appeared first on Camargo.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What It Feels Like To Quit Your Clinical Research Job

ECRG Media's Clinical Research Podcast

What It Feels Like To Quit Your Clinical Research Job Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Educatio

article thumbnail

Tips to Get More Doctor Referrals for your Pharma Franchise

Fossil Remedies

When you own a PCD franchise company , you aim to attain maximum profitability. For that, you need to reach as many doctors as possible who will endorse your products. Since the competition is fierce, your success depends on conveying and convincing doctors about the effectiveness and quality of your products. You can’t depend on 19 th -century marketing and communication methods in the 21 st century.

Doctors 52
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Drug development from bench to bedside

Deltaclinical

Yesterday we attended the symposium ‘Drug Development from Bench to Bedside’, organised by the University Hospital of Ghent. It was an interesting day on a great location with inspiring lectures. We’re looking forward to part 2 today. Find out more about the symposium.

article thumbnail

Our Best Blog Posts of 2019

Imperical Blog

Happy 2020 from Imperial Clinical Research Services! In welcoming the New Year, it’s a good time to reflect on the highlights of 2019 and look ahead to new opportunities. Imperial proudly provides clinical research-oriented blogs and ebooks provided by our diverse and knowledgeable subject matter experts (SMEs). Some of our popular categories include: Ancillary Supplies Business Insights Creative Writing and Design Life-Science Events Patient Recruitment and Retention Site Materials and Logistic

More Trending

article thumbnail

Horizon Discovery to provide access to novel base editing technology

Drug Discovery Today

Next-generation gene editing system has applications in development of cell and gene therapies. Base editing builds on CRISPR offering and will expand Horizon’s research tools and services.

article thumbnail

Drug development from bench to bedside

Deltaclinical

Yesterday we attended the symposium ‘Drug Development from Bench to Bedside’, organised by the University Hospital of Ghent. It was an interesting day on a great location with inspiring lectures. We’re looking forward to part 2 today. Find out more about the symposium. Het bericht Drug development from bench to bedside verscheen eerst op Deltaclinical.

article thumbnail

Should Blink Health advertise Canadian drugs on Google?

Pharmacy Checkers

The company Blink Health is advertising Canadian drugs on Google, even though it does not sell medication from Canadian pharmacies. Should the company do that? Is that false advertising? Blink Health advertising under the key phrase “drug prices in Canada” Launched in early 2016 , Blink Health offers consumers the ability to purchase prescription medicines from its app or website and pick them up from local pharmacies in their neighborhoods.

article thumbnail

What to Expect During a Recruiter Screen

ECRG Media's Clinical Research Podcast

What to Expect During a Recruiter Screen? Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education Send in a

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

EIT Health drives European healthcare innovation forward, awarding almost €6 million to pioneering start-ups

Drug Discovery Today

The participants of the EIT Health Headstart Programme will receive strong regional support and integration into the ecosystem, as well as funding to bring their innovations to the market. Headstart start-ups address disease areas and challenges from Parkinson’s to obesity, with the innovations spanning the categories of medtech, digital health and biotech.

article thumbnail

What to Expect During a Recruiter Screen

ECRG Media's Clinical Research Podcast

What to Expect During a Recruiter Screen? Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education.

article thumbnail

Evonetix collaborates with imec to scale-up chip-based technology production for third generation DNA synthesis platform

Drug Discovery Today

CAMBRIDGE, UK, and LEUVEN, Belgium, 13 January 2020 – EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene synthesis, today announced it has partnered with imec, a world-leading research and innovation hub active in the fields of nanoelectronics and digital technologies, to increase production of Evonetix’s proprietary microelectromechanical systems (MEMS)-based silicon chips, enabling the platform to be manufactured at

DNA 40
article thumbnail

CRA's Quick Tip To Get In Clinical Research Industry.

ECRG Media's Clinical Research Podcast

CRA's Quick Tip To Get In Clinical Research Industry In this episode a CRA gives a quick tip on how you should get into the clinical research industry. Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link] Send in a voice message: [link] CRA's Quick T

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

CRA's Quick Tip To Get In Clinical Research Industry.

ECRG Media's Clinical Research Podcast

CRA's Quick Tip To Get In Clinical Research Industry. In this episode a CRA gives a quick tip on how you should get into the clinical research industry. Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link].

article thumbnail

Avacta and Daewoong Pharmaceutical Form Immunotherapy Focused Joint Venture

Drug Discovery Today

Joint Venture to develop next generation cell and gene therapies incorporating Affimer proteins

article thumbnail

A new effort to tackle tuberculosis

Drug Discovery Today

Researchers at the University of Dundee are aiming to make a breakthrough against tuberculosis.

article thumbnail

New name announced for the Medicines Manufacturing Innovation Centre’s automated platform for Just in Time pharmaceutical manufacture

Drug Discovery Today

Innovation Centre’s automated platform for Just in Time pharmaceutical manufacture

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.